Anthony Fauci to HIV Infections
This is a "connection" page, showing publications Anthony Fauci has written about HIV Infections.
Connection Strength
1.889
-
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics. J Infect Dis. 2021 11 16; 224(9):1455-1461.
Score: 0.150
-
Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD. Am J Manag Care. 2020 07; 26(7):282-283.
Score: 0.136
-
An open-label phase 1 clinical trial of the anti-a4ß7 monoclonal antibody vedolizumab in HIV-infected individuals. Sci Transl Med. 2019 09 11; 11(509).
Score: 0.129
-
Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles. JAMA. 2019 Jul 02; 322(1):27-28.
Score: 0.127
-
Ending the HIV Epidemic: A Plan for the United States. JAMA. 2019 Mar 05; 321(9):844-845.
Score: 0.124
-
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019 Feb 05; 321(5):451-452.
Score: 0.124
-
Ending the HIV Epidemic in the United States: Closing the Implementation Gaps. Ann Intern Med. 2018 09 18; 169(6):411-412.
Score: 0.120
-
The Role of Integrin a4ß7 in HIV Pathogenesis and Treatment. Curr HIV/AIDS Rep. 2018 04; 15(2):127-135.
Score: 0.117
-
Ending the HIV/AIDS Pandemic1. Emerg Infect Dis. 2018 03; 24(3):413-416.
Score: 0.116
-
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci Transl Med. 2017 Dec 06; 9(419).
Score: 0.114
-
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic. JAMA. 2017 Oct 24; 318(16):1535-1536.
Score: 0.113
-
Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy. JAMA Cardiol. 2017 02 01; 2(2):123-124.
Score: 0.108
-
B-cell responses to HIV infection. Immunol Rev. 2017 01; 275(1):33-48.
Score: 0.107
-
Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol. 2003 Jun 15; 170(12):5965-72.
Score: 0.042
-
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002 Jun 15; 185(12):1818-21.
Score: 0.039
-
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to a4ß7. PLoS Pathog. 2018 08; 14(8):e1007278.
Score: 0.030
-
MAdCAM costimulation through Integrin-a4ß7 promotes HIV replication. Mucosal Immunol. 2018 09; 11(5):1342-1351.
Score: 0.030
-
PEPFAR - 15 Years and Counting the Lives Saved. N Engl J Med. 2018 Jan 25; 378(4):314-316.
Score: 0.029
-
Integrin a4ß7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes. Sci Transl Med. 2018 01 24; 10(425).
Score: 0.029
-
Reimagining the Research Approach to Tuberculosis†. Am J Trop Med Hyg. 2018 03; 98(3):650-652.
Score: 0.029
-
Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017 03 23; 543(7646):559-563.
Score: 0.027
-
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J Infect Dis. 2012 Nov; 206(9):1433-42.
Score: 0.020
-
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis. 2009 Jun 01; 199(11):1648-56.
Score: 0.016
-
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analyses. Blood. 2003 Nov 15; 102(10):3852-3.
Score: 0.011
-
Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog. 2012; 8(4):e1002636.
Score: 0.005